The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants
- PMID: 17433577
- DOI: 10.1016/j.earlhumdev.2007.03.001
The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants
Abstract
Background: The intestinal flora of breast-fed infants is generally dominated by bifidobacteria which have beneficial properties. Their presence is due to various compounds of breast milk including prebiotic substances.
Aim: This prospective, double blind, study compared the growth, acceptability and the proportion of bifidobacteria and clostridia in the stool flora of bottle-fed infants randomized to receive a formula with a specific mixture of 0.4 g/100 ml prebiotic galacto- and long-chain fructooligosaccharides or the same formula without added prebiotics.
Methods: Within 0-14 days after birth at term, healthy bottle-fed infants were enrolled to receive either a prebiotic formula or a standard formula. At recruitment anthropometric measurements were done. These were repeated at the age of 6 and 12 weeks. Stool samples were taken at inclusion and at the age of 6 weeks. The number of bifidobacteria and clostridia was determined by fluorescent in situ hybridization.
Results: There was good tolerance of the prebiotic formula. Somatic growth was similar in the two groups. Stool frequency was significantly higher in the prebiotic group (P=0.031). Infants in the prebiotic group had also softer stools as compared to the control group (P=0.026). Baseline values of microorganisms at study entry were similar. The percentage of faecal clostridia at the completion of the study was significantly lower in the prebiotic group (P=0.042), while the proportion of faecal bifidobacteria was higher in the prebiotic group as compared to the control group. However this difference did not reach statistical significance (P=0.262). The percentage of E. coli was lower in the prebiotic group but again this did not reach statistical significance (P=0.312).
Conclusion: An infant formula containing prebiotic oligosaccharides is well tolerated, leads to normal somatic growth and suppresses the numbers of clostridia in the faeces with a trend for higher percentage of stool bifidobacteria and lower percentage of E. coli.
Similar articles
-
The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants.Early Hum Dev. 2007 May;83(5):335-9. doi: 10.1016/j.earlhumdev.2006.07.003. Epub 2006 Sep 14. Early Hum Dev. 2007. PMID: 16978805 Clinical Trial.
-
Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding.J Pediatr Gastroenterol Nutr. 2008 May;46(5):580-8. doi: 10.1097/MPG.0b013e318164d920. J Pediatr Gastroenterol Nutr. 2008. PMID: 18493215 Clinical Trial.
-
[Randomised placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy infants].Orv Hetil. 2005 Nov 27;146(48):2445-50. Orv Hetil. 2005. PMID: 16408384 Clinical Trial. Hungarian.
-
Prebiotics in infant formulas.J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S76-9. doi: 10.1097/01.mcg.0000128927.91414.93. J Clin Gastroenterol. 2004. PMID: 15220664 Review.
-
Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review.Acta Paediatr Suppl. 2005 Oct;94(449):22-6. doi: 10.1111/j.1651-2227.2005.tb02150.x. Acta Paediatr Suppl. 2005. PMID: 16214761 Review.
Cited by
-
Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial.Eur J Nutr. 2015 Feb;54(1):89-99. doi: 10.1007/s00394-014-0689-9. Epub 2014 Mar 27. Eur J Nutr. 2015. PMID: 24671237 Free PMC article. Clinical Trial.
-
Specific synbiotics in early life protect against diet-induced obesity in adult mice.Diabetes Obes Metab. 2018 Jun;20(6):1408-1418. doi: 10.1111/dom.13240. Epub 2018 Mar 5. Diabetes Obes Metab. 2018. PMID: 29460474 Free PMC article.
-
The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial.J Res Pharm Pract. 2016 Jan-Mar;5(1):27-34. doi: 10.4103/2279-042X.176558. J Res Pharm Pract. 2016. PMID: 26985433 Free PMC article.
-
An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders.Nutrients. 2021 Sep 23;13(10):3336. doi: 10.3390/nu13103336. Nutrients. 2021. PMID: 34684337 Free PMC article.
-
Prebiotic utilisation provides Lactiplantibacillus plantarum a competitive advantage in vitro, but is not reflected by an increased intestinal fitness.Gut Microbes. 2024 Jan-Dec;16(1):2338946. doi: 10.1080/19490976.2024.2338946. Epub 2024 Apr 24. Gut Microbes. 2024. PMID: 38656273 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical